SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-004113
Filing Date
2022-01-13
Accepted
2022-01-13 19:04:40
Documents
2
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm222949-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm222949-1_4seq1.xml 4 3496
2 POWER OF ATTORNEY tm222949d1_ex24-1.htm EX-24.1 7732
  Complete submission text file 0001104659-22-004113.txt   12673
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
BALL BRYAN (Reporting) CIK: 0001766522 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 22530098